Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Teva
Cipla
Citi
Novartis
Colorcon
Baxter
Chubb
Healthtrust

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020047

« Back to Dashboard

NDA 020047 describes DEXTROSE 70% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in four NDAs. It is available from two suppliers. Additional details are available on the DEXTROSE 70% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 70% IN PLASTIC CONTAINER is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for 020047
Tradename:DEXTROSE 70% IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare
Ingredient:dextrose
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020047
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047 NDA Baxter Healthcare Corporation 0338-0719 0338-0719-13 500 mL in 1 BAG (0338-0719-13)
DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047 NDA Baxter Healthcare Corporation 0338-0719 0338-0719-13 500 mL in 1 BAG (0338-0719-13)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50GM/100ML
Approval Date:Jul 2, 1991TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength60GM/100ML
Approval Date:Jul 2, 1991TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength70GM/100ML
Approval Date:Jul 2, 1991TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Colorcon
US Department of Justice
UBS
Boehringer Ingelheim
Chinese Patent Office
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot